Methods for transducing cells in blood vessels using recombinant AAV vectors

• US 20020001581A1
• Filed: 08/23/2001
• Published: 01/03/2002
• Est. Priority Date: 03/04/1996
• Status: Abandoned Application

• Current Assignee: Carmel M. Lynch, Randolph L. Geary
• Original Assignee: Carmel M. Lynch, Randolph L. Geary
• Inventors: Geary, Randolph L., Lynch, Carmel M.
• Application Number:
  US09/938,200
• Publication Number:
  US 20020001581A1
• Time in Patent Office: Days
• US Class Current: 424/93.21
• CPC Class Codes: A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
• CPC Class Codes: C12N 15/86 Viral vectors
• CPC Class Codes: C12N 2750/14143 viral genome or elements thereof as genetic vector

Abstract

Current techniques for expressing recombinant genes in cells of blood vessels following direct in vivo gene transfer are limited by attendant problems or limitations. Further, an effective method of transducing microvascular cells and/or cells involved in formation of new blood vessels (angiogenesis) has not been demonstrated. This invention provides methods of transducing cells in blood vessels using recombinant adeno-associated virus (AAV) vectors.

Claims

1. A method of transducing a cell in a blood vessel of an individual, comprising introducing a recombinant adeno-associated viral (rAAV) vector to a blood vessel of said individual in vivo.

2. A method of transducing a cell in a blood vessel according to claim 1, wherein said rAAV vector comprises a detectable marker gene.

3. A method of transducing a cell in a blood vessel according to claim 1, wherein said rAAV vector comprises a selectable marker gene.

4. A method of transducing a cell in a blood vessel according to claim 1, wherein said rAAV vector comprises a therapeutic gene.

5. A method of transducing a cell in a blood vessel according to claim 1, wherein said blood vessel is a micro vessel selected from the group consisting of arteriole, capillary, venule, and adventitial microvessel.

6. A method of transducing a cell in a blood vessel according to claim 5, wherein said blood vessel is an adventitial microvessel.

7. A method of transducing a cell in a blood vessel according to claim 1, wherein said blood vessel is a microvessel and said cell is undergoing proliferation

8. A method of transducing a cell in a blood vessel according to claim 1, wherein said cell is a primate cell.

9. A method of transducing a cell in a blood vessel according to claim 8, wherein said c ell is a human cell.

10. A method of transducing a cell in a blood vessel according to claim 1, wherein said cell is a proliferating cell.

11. A method of transducing a cell in a blood vessel according to claim 10, wherein said cell is a proliferating microvascular cell.

12. A method of transducing a cell in a blood vessel according to claim 1, wherein said cell is a microvascular cell.

13. A method of transducing a cell in a blood vessel according to claim 12, wherein said cell is a microvascular endothelial cell.

14. A method of transducing a cell in a blood vessel according to claim 1, wherein said rAAV vector is introduced into the adventitia of an artery of said individual.

16. A method for treating an individual for a disease condition, comprising transducing a cell in a blood vessel of said individual according to the method of claim 4.

15. A transduced microvascular cell produced by introducing a recombinant adeno-associated viral (rAAV) vector to said microvascular cell.